Literature DB >> 11731912

In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54.

O Kayser1, A F Kiderlen, R Brun.   

Abstract

A series of naturally occurring aurones (e. g., Rubiaceae, Cyperaceae) was synthesized and tested for the ability to inhibit erythrocytic stages of Plasmodium falciparum strains in vitro. Some of the these compounds exhibited antiplasmodial activity in the micromol range, determined as fifty percent-inhibitory concentrations (IC(50)). Drug activity was not associated with cytotoxicity for the mammalian tumor cell lines KB and SKMel (IC(50) > 3.0 microM). The most active compound was 4,6,4'-triacetyl-3',5'-dimethoxy-2-aurone with IC(50) values of 0.007 microM and 0.18 microM for the P. falciparum strains K1 and NF54, respectively. Interestingly, the multiple drug-resistant P. falciparum strain K1 was more sensitive to tested aurones than the drug-susceptible strain NF54.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731912     DOI: 10.1055/s-2001-18356

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  Natural products as antiparasitic drugs.

Authors:  O Kayser; A F Kiderlen; S L Croft
Journal:  Parasitol Res       Date:  2003-02-20       Impact factor: 2.289

2.  In Vitro Antiplasmodial Activity and Cytotoxic Effect of (Z)-2-Benzylidene-4, 6-Dimethoxybenzofuran-3(2H)-One Derivatives.

Authors:  Ali Ramazani; Reza Hamidnezhad; Alireza Foroumadi; Seyed Abbas Mirzaei; Somayyeh Maddahi; Seyed Mehdi Hassanzadeh
Journal:  Iran J Parasitol       Date:  2016 Jul-Sep       Impact factor: 1.012

3.  Aurone-derived 1,2,3-triazoles as potential fluorescence molecules in vitro.

Authors:  Daniel L Bryant; Arjun Kafle; Scott T Handy; Anthony L Farone; Justin M Miller
Journal:  RSC Adv       Date:  2022-08-12       Impact factor: 4.036

Review 4.  Therapeutic Potential of Pterocarpus santalinus L.: An Update.

Authors:  Saradamma Bulle; Hymavathi Reddyvari; Varadacharyulu Nallanchakravarthula; Damodara Reddy Vaddi
Journal:  Pharmacogn Rev       Date:  2016 Jan-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.